Investigation of effects of Lacidipine, Ramipril and Valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats

Molecular and Cellular Biochemistry

Volumn 328, Issue 1-2, 2009, Pages 109-117

  Keles, Mevlut Sait ^a   Bayir, Yasin ^b   Suleyman, Halis ^a   Halici, Zekai ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

DNA damage; Isoproterenol; Lacidipine; Myocardial infarction; Ramipril; Rat; Valsartan

Indexed keywords

8 HYDROXYGUANINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE ISOENZYME; ISOPRENALINE; LACIDIPINE; LACTATE DEHYDROGENASE; NITRIC OXIDE; RAMIPRIL; TROPONIN I; VALSARTAN;

ACUTE HEART INFARCTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA DAMAGE; DRUG EFFICACY; DRUG MECHANISM; ENZYME BLOOD LEVEL; HEART HEMODYNAMICS; HEART INFARCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; TREATMENT RESPONSE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; DIHYDROPYRIDINES; DNA DAMAGE; GUANINE; ISOPROTERENOL; MYOCARDIAL INFARCTION; NITRIC OXIDE; OXIDATIVE STRESS; RAMIPRIL; RATS; TETRAZOLES; VALINE;

RATTUS;

EID: 67650240164     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0080-y     Document Type: Article

References (53)

1. Maxwell SR, Lip GY (1997) Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58:95-117. doi: 10.1016/S0167-5273(96)02854-9
2. Wexler BC, Greenberg BP (1978) Protective effects of clofibrate on Isoproterenol-induced myocardia-linfarction in arteriosclerotic and non-arteriosclerotic rats. Atherosclerosis 29:373-395. doi: 10.1016/ 0021-9150(78)90084-9 373-395.
3. Yeager JC, Iams SG (1981) The hemodynamics of isoproterenol-induced cardiac failure in the rat. Circ Shock 8:151-163
4. Bloom S, Davis Dl (1972) Calcium as mediator of isoproterenol-induced myocardial necrosis. Am J Pathol 69:459-470
5. Fleckenstein A, Janke J, Doring HJ et al (1974) Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology. Recent Adv Stud Cardiac Struct Metab 4:563-580
6. Sharma M, Kishore K, Gupta SK et al (2001) Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 225:75-83. doi: 10.1023/A:1012220908636
7. Miwa S, Toyokuni S, Nishina T et al (2002) Spaciotemporal alteration of 8-hydroxy-2′-deoxyguanosine levels in cardiomyocytes after myocardial infarction in rats. Free Radic Res 36:853-858. doi: 10.1081/ 1071576021000005285
8. Dizdaroglu M, Jaruga P, Birincioglu M et al (2002) Free radical-induced damage to DNA: Mechanisms and measurement. Free Radic Biol Med 32:1102-1115. doi: 10.1016/S0891-5849(02)00826-2
9. Kasai H, Nishimura S (1984) Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 12:2137-2145. doi: 10.1093/nar/12.4.2137
10. Kasai H (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387:147-163. doi: 10.1016/ S1383-5742(97)00035-5
11. Floyd RA, Watson JJ, Wong PK et al (1986) Hydroxyl free radical adduct of deoxyguanosine: Sensitive detection and mechanisms of formation. Free Radic Res Commun 1:163-172. doi: 10.3109/10715768609083148
12. Van't Hof RJ, Ralston SH (2001) Nitric oxide and bone. Immunology 103:255-261. doi: 10.1046/j.1365-2567.2001.01261.x
13. Yucel D, Senes M, Topkaya B et al (2006) Oxidative/nitrosative stress in chronic heart failure: A critical review. Turk J Biochem 31:86-95
14. Hertog MG, Feskens EJ, Hollman PC et al (1993) Dietary antioxidant flavonoids and risk of coronary heart-disease - the zutphen elderly study. Lancet 342:1007-1011. doi: 10.1016/0140-6736(93)92876-U
15. Gupta SK, Mohanty I, Talwar KK et al (2004) Cardioprotection from ischemia and reperfusion injury by Withania somnifera: A hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem (260):39-47
16. Sumitra M, Manikandan P, Kumar DA et al (2001) Experimental myocardial necrosis in rats: Role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem 224:135-142
17. Kyselovic J, Krenek P, Wibo M et al (2001) Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats. Br J Pharmacol 134:1516-1522. doi: 10.1038/sj.bjp.0704398
18. Wolkart G, Pang X, Stessel H et al (2007) Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats. Br J Pharmacol 151:1187-1197. doi: 10.1038/sj.bjp.0707325
19. Cm Y, Wing-Hon LK, Li PS et al (2004) Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: A new mechanism of action. J Mol Cell Cardiol 36:445-453. doi: 10.1016/j.yjmcc.2004.01.002
20. Rona G, Chappel CI, Balazs T et al (1959) An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol 67:443-455
21. ECCLS (1989) Determination of catalytic concentration in serum of l -alanine aminotransferase (E.C. 2.6.1.2, ALAT). Klin Chem Mitt 20:204-211
22. ECCLS (1989) Determination of catalytic concentration in serum of L-aspartate aminotransferase (E.C. 2.6.1.1, ASAT). Klin Chem Mitt 20:198-204
23. Schumann G, Bonora R, Ceriotti F et al (2002) IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C. Part 3. Reference procedure for the measurement of catalytic concentration of lactate dehydrogenase. Clin Chem Lab Med 40(6):643-648
24. Lott JA, Stang JM (1980) Serum enzymes and isoenzymes in the diagnosis and differantial diagnosis of mycardial ischemia and necrosis. Clin Chem 26:1241-1250
25. Wu AH, Feng YJ, Moore R et al (1998) Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 44(6 Pt 1):1198-1208
26. Moshage H, Kok B, Huizenga JR et al (1995) Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 41:892-896
27. Adeli K, Ogbonna G (1990) Rapid purification of human DNA from whole blood for potential application in clinical chemistry laboratories. Clin Chem 36:261-264
28. Kaur H, Halliwell B (1996) Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem J 318(Pt 1):21-23
29. Sathish V, Ebenezar KK, Devaki T (2003) Synergistic effect of Nicorandil and Amlodipine on tissue defense system during experimental myocardial infarction in rats. Mol Cell Biochem 243:133-138. doi: 10.1023/ A:1021612230000
30. Jayalakshmi R, Thirupurasundari CJ, Devaraj SN (2006) Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol-induced myocardial infarction in rats. Mol Cell Biochem 292:59-67. doi: 10.1007/s11010-006-9218-3
31. Whealthy AM, Thandroyen FT, Opie LH (1985) Catecholamine induced myocardial cell damage: Catecholamines or adrenochrome. J Mol Cell Cardiol 17:349-359. doi: 10.1016/S0022-2828(85)80134-6
32. Rajadurai M, Prince PS (2007) Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: An in vivo and in vitro study. Toxicology 232:216-225. doi: 10.1016/j.tox.2007.01.006
33. Brodde OE (1991) Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43:203-242
34. Remiao F, Carmo H, Carvalho F et al (2001) Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: Effects on oxidative stress. Cardiovasc Toxicol 1:195-204. doi: 10.1385/CT:1:3:195
35. Rajadurai M, P Stanely Mainzen Prince (2006) Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: Biochemical and histopathological evidences. Toxicology 228:259-268. doi: 10.1016/j.tox.2006.09.005
36. Wittevean Sagi AGJ, Hemker HC, Hollar L, Hermens W (1975) The quantification of infarct size in man by means of plasma enzyme levels. Br Heart J 37:795-803. doi: 10.1136/hrt.37.8.795
37. Suchalatha S, Shyamaladevi CS (2004) Effect of arogh - a polyherbal formulation on the marker enzymes in isoproterenol induced myocardial linjury. Indian J Clin Biochem 19:184-189. doi: 10.1007/BF02894283
38. Adams JE 3rd, Bodor GS, Dávila-Román VG et al (1993) Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88:101-106
39. Puleo PR, Meyer D, Wathen C et al (1994) Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 331:561-566. doi: 10.1056/NEJM199409013310901
40. Acikel M, Buyukokuroglu ME, Erdogan F et al (2005) Protective effects of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings. Int J Cardiol 98:389-394. doi: 10.1016/j.ijcard.2003.10.054
41. Van Amsterdam FT, Roveri A, Maiorino M et al (1992) Lacidipine: A dihydropyridine calcium antagonist with antioxidant activity. Free Radic Biol Med 12:183-187. doi: 10.1016/0891-5849(92)90025-C
42. Aslam S (2008) Cardiovascular disease in dialysis patients: Do some antihypertensive drugs have specific antioxidant effects or is it just blood pressure reduction? Does antioxidant treatment reduce the risk for cardiovascular disease? Curr Opin Nephrol Hypertens 17:99-105
43. Lei SZ, Pan ZH, Aggarwal SK et al (1992) Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-1099. doi: 10.1016/0896-6273(92)90130-6
44. Siegfried MR, Erhardt J, Rider T et al (1992) Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 260:668-675
45. Collins AR, Dusinska M, Gedik CM et al (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 104(Suppl 3):465-469. doi: 10.2307/3432805
46. Jornot L, Petersen H, Junod AF (1998) Hydrogen peroxide-induced DNA damage is independent of nuclear calcium but dependent on redox-active ions. Biochem J 335(Pt 1):85-94
47. Cooke MS, Evans MD, Dizdaroglu M et al (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214. doi: 10.1096/ fj.02-0752rev
48. Cadet J, Douki T, Gasparutto D et al (2003) Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res 531:5-23. doi: 10.1016/j.mrfmmm.2003.09.001
49. Dizdaroglu M (1994) Chemical determination of oxidative DNA damage by gas chromatography-mass spectrometry. Methods Enzymol 234:3-16. doi: 10.1016/0076-6879(94)34072-2
50. Shigenaga MK, Aboujaoude EN, Chen Q et al (1994) Assays of oxidative DNA damage biomarkers 8-oxo-2′-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 234:16-33. doi: 10.1016/0076-6879(94)34073-0
51. Evans MD, Cooke MS, Podmore ID et al (1999) Discrepancies in the measurement of UVC-induced 8-oxo-2′-deoxyguanosine: Implications for the analysis of oxidative DNA damage. Biochem Biophys Res Commun 259:374-378. doi: 10.1006/bbrc.1999.0801
52. Kasai H, Nishimura S (1991) Formation of 8-hydroxydeoxyguanosine in DNA. In: Sies H (ed) OxidativX stress:oxidants and antioxidants. Academic Press, London, pp 99-116
53. Shigenaga MK, Gimeno CJ, Amens BN (1989) Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 86:9697-9701. doi: 10.1073/ pnas.86.24.9697